Table 1. DEMOGRAPHIC FACTORS, COMORBID CONDITIONS, HISTOLOGIC SUBTYPES, AND TREATMENT-RELATED FACTORS

* Soft tissue sarcoma (n = 5), pancreatic lymphoma (n = 1), renal cell carcinoma (n = 1), or colon cancer (n = 1).

** Etoposide and ifosfamide (1 patient), carboplatin and 5-fluorouracil (1 patient), or interferon-2α (1 patient).

† One patient with prereferral biliary bypass had bypass occlusion managed by preoperative endobiliary stent placement. This patient is analyzed in the prosthetic biliary drainage group.

‡ Colon (n = 10), kidney (n = 3), or liver (right hepatectomy, n = 1).